About this trial
Three-arm randomized clinical trial comparing two strategies of TcMS to sham stimulation in patients with VT storm. The hypothesis of the study is that TcMS will reduce the burden of VT in the 24 hours after randomization compared to sham stimulation and that TcMS with theta burst stimulation (TBS) will be more effective at reducing VT burden than low frequency TcMS.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥3 episodes of sustained VT or appropriate ICD therapies within 24 hours despite the use of at least one antiarrhythmic drug
Disqualifiers
Plan for catheter ablation of VT in the next 24 hours
Pregnancy
Contraindication to TcMS (i.e. implantable ventricular assist device, metal implanted in the head or neck [except the mouth], implanted medication pumps, cochlear implant, implanted brain stimulator, ocular implant, history of malignancy in the neck)
Trial design
Parallel
Treatments tested in this trial
Magnetic Stimulation
DeviceTranscutaneous Magnetic Stimulation
Treatment groups
Trial outcomes
Primary outcomes
VT Burden (24 hours)
Number of episodes of sustained ventricular tachycardia
Secondary outcomes
VT burden (72 hours)
Number of episodes of sustained ventricular tachycardia
Freedom from VT
Freedom from sustained VT
Blood Pressure
Change in mean arterial blood pressure
Heart Rate
Change in heart rate
Sponsors and contacts
Click on the lead sponsor to view all of their trials.